Bomyntra Injection
Product Images NDC 65219-672

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Bomyntra (NDC 65219-672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tra1b 0001 01)

This text is not readable.*

FDA Label Image

Figure A (Tra1b 0001 02)

FDA Label Image

Figure B (Tra1b 0001 03)

FDA Label Image

Figure C (Tra1b 0001 04)

FDA Label Image

Figure D (Tra1b 0001 05)

FDA Label Image

Figure 1 (Tra1b 0001 06)

This data showcases calcium levels in two groups along with the administration of Denosumab 120 mg to 23 individuals. The table includes values over several days, showing a gradual decline, and points to a subsequent increase. The corrected calcium values are presented in mmol/L and mа/dL.*

FDA Label Image

Logo (Tra1b 0001 07)

FDA Label Image

Principal Display Panel – 120 mg/1.7 mL Pfs Carton Label (Tra1b 0001 08)

This text appears to be related to the product information for an injection called Bomyntra. It is a sterile solution with no preservative and comes in a single-dose prefilled syringe. The injection contains denosumab-bnht and has a dosage of 120 mg/1.7 mL (70 mg/mL). It is meant for subcutaneous use only and should be administered by a healthcare provider. The carton includes one single-dose prefilled syringe and prescribing information. It is important not to accept the product if the seal is broken or missing.*

FDA Label Image

Principal Display Panel – 120 mg/1.7 mL Syringe Label (Tra1b 0001 09)

This is a description for a medication named Bomyntra, specifically denosumab-bnht injection. It contains 120 mg and is for subcutaneous use only. The manufacturer is Fresenius Kabi USA, LLC. The medication is only available with a prescription (Rx only).*

FDA Label Image

Principal Display Panel – 120 mg/1.7 mL Carton Label (Tra1b 0001 10)

FDA Label Image

Principal Display Panel – 120 mg/1.7 mL Syringe Label (Tra1b 0001 11)

This is a prescription medication by Fresenius Kabi. It is an injection with a concentration of 120 mg/1.7 mL (70 mg/mL) intended for subcutaneous use only. The medication comes in a single-dose vial, and any unused portion should be discarded.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.